PharmaCielo Enters Into Agreement To Acquire Medical Marijuana Company Creso Pharma

PharmaCielo Ltd. (TSXV:PCLO) announced it entered into an implementation agreement with Creso Pharma Ltd. (ASX:CPH) to acquire all of Creso’s issued and outstanding shares and listed options.

The deal is for approximately A$122 million (about $85.2 million USD). PharmaCielo will pay 63 cents for each Creso share. Both PharmaCielo and Creso’s board of directors have unanimously approved the deal.

Need more cannabis news? Check out all of our coverage here.

Why It Matters

The acquisition is expected to give PharmaCielo …

Full story available on Benzinga.com

More PharmaCielo Enters Into Agreement To Acquire Medical Marijuana Company Creso Pharma